Actemra 200mg, a drug known scientifically as tocilizumab, functions as a potent pharmaceutical agent primarily utilized for the control of rheumatoid arthritis. This effective compound acts by interfering with the activity of interleukin-6 (IL-6), a regulatory protein essential in the inflammatory process. Additionally, Actemra exhibits efficacy